European Archives - Page 13 of 1163 - European Medical Journal

Evaluating ChatGPT’s Role in Urological Education

Students using ChatGPT alone scored lower than those attending lectures suggesting that AI tools may not sufficiently support complex learning.

Global Study Reveals Wide Gaps in Paediatric Bronchiectasis Care

New global registry study reveals stark regional differences in diagnosis, treatment, and care quality for children with bronchiectasis.

Tracking A&E Demand in Sickle Cell Disease

A new cohort study analysing over 100,000 A&E visits in North Carolina has redefined what constitutes high emergency care use among people with sickle cell disease.

Cannabis Use Linked to Increased Cardiovascular Health Risks

THC, the main psychoactive compound, can stimulate the sympathetic nervous system, potentially causing tachycardia, vasoconstriction, and increased oxygen demand.

Lifestyle Changes Improve Liver Health in Patients with HIV

The findings highlight the potential for behavioural strategies, such as dietitian-led interventions, to play a key role in managing liver health.

FDA investigates trials sending US cells to foreign labs

The FDA has launched an immediate review of clinical trials involving the export of American patients’ living cells to China and other “hostile countries”.

Project to transform drug manufacturing wins £1.8m

A UK project has received a £1.8m to transform how medicines are made, aiming to make drug manufacturing faster, cleaner and more responsive.

Over 40% of Lupus Patients Lack Enough Exercise

An international study shows that many people with lupus are not physically active enough, with low activity levels linked to worse fatigue, stress, and depression.

High Readmission Rates Persist for Patients with Sickle Cell in Hospitals

A large-scale US study reveals that 34% of sickle cell disease patients are readmitted within 30 days of hospital discharge, nearly triple the rate of non-SCD patients.

Widely Used Painkiller Significantly Alters Gut Microbiota

Genetic data show that salicylic acid may alter gut microbiota and blood metabolites, raising questions about its long-term effects.